Get All Access for $5/mo

Walgreens Boots Alliance Gets Bill for $2.7 Billion From the IRS After Tax Audit 'Tis the (tax) season.

By Emily Rella

Opinions expressed by Entrepreneur contributors are their own.

No one is safe from the IRS this tax season — and multi-billion dollar corporation Walgreens just received a hefty audit from the government.

According to a filing with the U.S. Securities and Exchange Commission on February 29, Walgreens Boots Alliance was hit with a $2.7 billion bill by the IRS after audits the agency conducted allegedly found problems with Walgreens' transfer pricing between 2014 and 2017.

"The Company intends to vigorously defend its position on the transfer pricing matter through the IRS's administrative appeals office and, if necessary, judicial proceedings and is confident in its ability to prevail on the merits," the SEC filing said on behalf of Walgreens.

Walgreens Boots Alliance oversees Walgreens in the U.S. and Boots drugstores in the U.K.

"We believe that we will prevail at the conclusion of the audit," a spokesperson for Walgreens told the Chicago Tribune.

Related: Walgreens Unveils New CEO, $1 Billion Cost-Cutting Plan

According to Investopedia, transfer pricing is defined as an "accounting practice that represents the price that one division in a company charges another division for goods and services provided," which is often used to help lower the overall "tax burden of the parent company."

The IRS is seeking additional tax payments, interest, and penalties in its total compensation from Walgreens.

The audit can take between two to seven years to complete, according to Bloomberg.

Related: Walgreens Boots Alliance Exec Vice President: Raise My Taxes

Walgreens Boots Alliance joins other large corporations, including Meta, Apple, and Microsoft that are also facing IRS audits over transfer pricing issues.

Last fall, Walgreens unveiled a plan to reduce costs by $1 billion after reporting a weak fiscal 2023, which resulted in operating losses of $6.9 billion for the year due to opioid-related lawsuits and other litigation issues.

Amid the losses, Walgreens is now unveiling an aggressive cost-cutting plan, including closing 60 of its clinics, Axios reported.

Emily Rella

Senior News Writer

Emily Rella is a Senior News Writer at Entrepreneur.com. Previously, she was an editor at Verizon Media. Her coverage spans features, business, lifestyle, tech, entertainment, and lifestyle. She is a 2015 graduate of Boston College and a Ridgefield, CT native. Find her on Twitter at @EmilyKRella.

Want to be an Entrepreneur Leadership Network contributor? Apply now to join.

Editor's Pick

Business News

Nvidia CEO Jensen Huang Says Nuclear Energy 'Is a Wonderful Way Forward' to Keep AI Data Centers Running

AI could use as much electricity as a small country within the next three years.

Growing a Business

How This Software Company Is Simplifying Complex But Critical Processes for Small Businesses

Gusto CEO Josh Reeves shares his commitment to small businesses and growth lessons that any business can use.

Money & Finance

How Recessions Create Wealth-Building Opportunities for Savvy Investors

Let's discuss how savvy, contrarian investors can capitalize on distressed assets during economic downturns.

Leadership

Why Every Leader Should Prioritize Reading

Reading isn't just a chore; it's an investment in your personal and professional growth.